Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Pediatric Research
|
February 19, 2005
The selective class III/V receptor tyrosine kinase inhibitor SU11657 inhibits tumor growth and angiogenesis in experimental neuroblastomas grown in mice
Ulrika Bäckman, Rolf Christofferson
Angiogenesis
|
August 9, 2003
Importance of vascular endothelial growth factor A in the progression of experimental neuroblastoma
Ulrika Bäckman, Asa Svensson, Rolf Christofferson
Anticancer Research
|
July 18, 2008
The bisphosphonate, zoledronic acid reduces experimental neuroblastoma growth by interfering with tumor angiogenesis
Ulrika Bäckman, Asa Svensson, Rolf H Christofferson, et al.
Anticancer Research
|
January 30, 2008
Angiogenesis can be reduced without significant reduction of tumor growth
Asa Svensson, Ulrika Bäckman, Dieter Fuchs, et al.
Anticancer Research
|
April 9, 2005
Digoxin inhibits neuroblastoma tumor growth in mice
Asa Svensson, Faranak Azarbayjani, Ulrika Bäckman, et al.
Pediatric Research
|
April 30, 2002
CHS 828 inhibits neuroblastoma growth in mice alone and in combination with antiangiogenic drugs
Asa Svensson, Ulrika Bäckman, Elin Jonsson, et al.
Pediatric Research
|
September 22, 2006
The anti-VEGF antibody bevacizumab potently reduces the growth rate of high-risk neuroblastoma xenografts
Lova Segerström, Dieter Fuchs, Ulrika Bäckman, et al.
BMC Health Services Research
|
February 3, 2012
How does lean work in emergency care? A case study of a lean-inspired intervention at the Astrid Lindgren Children's hospital, Stockholm, Sweden
Pamela Mazzocato, Richard J Holden, Mats Brommels, et al.
Journal of Health Organization and Management
|
July 29, 2014
Complexity complicates lean: lessons from seven emergency services
Pamela Mazzocato, Johan Thor, Ulrika Bäckman, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Pediatric Research
|
February 19, 2005
The selective class III/V receptor tyrosine kinase inhibitor SU11657 inhibits tumor growth and angiogenesis in experimental neuroblastomas grown in mice
Ulrika Bäckman, Rolf Christofferson
Angiogenesis
|
August 9, 2003
Importance of vascular endothelial growth factor A in the progression of experimental neuroblastoma
Ulrika Bäckman, Asa Svensson, Rolf Christofferson
Anticancer Research
|
July 18, 2008
The bisphosphonate, zoledronic acid reduces experimental neuroblastoma growth by interfering with tumor angiogenesis
Ulrika Bäckman, Asa Svensson, Rolf H Christofferson, et al.
Anticancer Research
|
January 30, 2008
Angiogenesis can be reduced without significant reduction of tumor growth
Asa Svensson, Ulrika Bäckman, Dieter Fuchs, et al.
Anticancer Research
|
April 9, 2005
Digoxin inhibits neuroblastoma tumor growth in mice
Asa Svensson, Faranak Azarbayjani, Ulrika Bäckman, et al.
Pediatric Research
|
April 30, 2002
CHS 828 inhibits neuroblastoma growth in mice alone and in combination with antiangiogenic drugs
Asa Svensson, Ulrika Bäckman, Elin Jonsson, et al.
Pediatric Research
|
September 22, 2006
The anti-VEGF antibody bevacizumab potently reduces the growth rate of high-risk neuroblastoma xenografts
Lova Segerström, Dieter Fuchs, Ulrika Bäckman, et al.
BMC Health Services Research
|
February 3, 2012
How does lean work in emergency care? A case study of a lean-inspired intervention at the Astrid Lindgren Children's hospital, Stockholm, Sweden
Pamela Mazzocato, Richard J Holden, Mats Brommels, et al.
Journal of Health Organization and Management
|
July 29, 2014
Complexity complicates lean: lessons from seven emergency services
Pamela Mazzocato, Johan Thor, Ulrika Bäckman, et al.
Page
of 1